Literature DB >> 2152945

Induction by interleukin-2 of oligoclonal expansion of cultured tumor-infiltrating lymphocytes.

A J Fishleder1, J H Finke, R Tubbs, R M Bukowski.   

Abstract

To better understand the modulatory effects of interleukin-2 (IL-2) on lymphocyte proliferation, we examined the clonality of the in vitro T-cell response by Southern blot hybridization. Tumor-infiltrating lymphocytes (TILs) grown in the presence of IL-2 for 15-26 days had detectable T-cell receptor beta-chain gene rearrangements, which indicated oligoclonal enhancement in culture in four of nine TIL samples. In contrast, none of 11 uncultured TIL samples had detectable gene rearrangements. Lack of detection in at least three of the five negative, cultured TIL samples could be explained by increased numbers of natural killer cells. We hypothesize that the oligoclonal expansion noted results from the enhanced response of immune-primed T cells to IL-2.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2152945     DOI: 10.1093/jnci/82.2.124

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  7 in total

1.  Oligoclonality of CD8+ T cells in breast cancer patients.

Authors:  K Ito; J Fetten; H Khalili; S Hajdu; E Busch; R Pergolizzi; V Vinciguerra; M D Chang
Journal:  Mol Med       Date:  1997-12       Impact factor: 6.354

2.  Cytotoxic activity and T cell receptor repertoire in tumor-infiltrating lymphocytes of adrenal cell carcinomas.

Authors:  Y Yamamoto; K Backlin; H Nakagomi; E Halapi; C Juhlin; A Bucht; R Kiessling
Journal:  Cancer Immunol Immunother       Date:  1993-08       Impact factor: 6.968

3.  Oligoclonal expansion of V beta 8+ cells in interleukin-2-activated T cells residing in subcutaneous metastatic melanoma.

Authors:  T Morita; M A Salmeron; R P Moser; M I Ross; K Itoh
Journal:  Clin Exp Metastasis       Date:  1992-01       Impact factor: 5.150

4.  Restricted T cell receptor V-beta and J-beta usage in T cells from interleukin-2-cultured lymphocytes of ovarian and renal carcinomas.

Authors:  E Halapi; Y Yamamoto; C Juhlin; M Jeddi-Tehrani; J Grunewald; R Andersson; C Hising; G Masucci; H Mellstedt; R Kiessling
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

5.  T cell receptor gene rearrangements and cytotoxic activities of clones isolated from tumour-infiltrating lymphocytes (TIL) from melanoma patients.

Authors:  F Pandolfi; L A Boyle; L Trentin; A Oliva; J T Kurnick
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

6.  Analysis of T cell receptor beta and gamma genes from peripheral blood, regional lymph node and tumor-infiltrating lymphocyte clones from melanoma patients.

Authors:  M R Albertini; J A Nicklas; B F Chastenay; T C Hunter; R J Albertini; S S Clark; J A Hank; P M Sondel
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

7.  Increase in the ability of human cancer cells to induce cytotoxic T lymphocytes by ultraviolet irradiation.

Authors:  Y Umezu; L B Augustus; D Seito; K Hayakawa; M I Ross; O Eton; D A Swanson; K Itoh
Journal:  Cancer Immunol Immunother       Date:  1993-11       Impact factor: 6.968

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.